NEW YORK, March 20, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Home Bancorp, Inc. (NASDAQ:HBCP), Gorman-Rupp Company (NYSE:GRC), Aratana Therapeutics, Inc. (NASDAQ:PETX), Washington Real Estate Investment Trust (NYSE:WRE), XG Technology, Inc (NASDAQ:XGTI), and Hope Bancorp, Inc. (NASDAQ:HOPE), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
HBCP DOWNLOAD: http://Fundamental-Markets.com/register/?so=HBCP
GRC DOWNLOAD: http://Fundamental-Markets.com/register/?so=GRC
PETX DOWNLOAD: http://Fundamental-Markets.com/register/?so=PETX
WRE DOWNLOAD: http://Fundamental-Markets.com/register/?so=WRE
XGTI DOWNLOAD: http://Fundamental-Markets.com/register/?so=XGTI
HOPE DOWNLOAD: http://Fundamental-Markets.com/register/?so=HOPE
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine Home Bancorp, Inc. (NASDAQ:HBCP), Gorman-Rupp Company (NYSE:GRC), Aratana Therapeutics, Inc. (NASDAQ:PETX), Washington Real Estate Investment Trust (NYSE:WRE), XG Technology, Inc (NASDAQ:XGTI), and Hope Bancorp, Inc. (NASDAQ:HOPE) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed March 16th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
HOME BANCORP, INC. (HBCP) REPORT OVERVIEW
Home's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Home reported interest income of $21.97MM vs $16.92MM (up 29.83%) and basic earnings per share $0.42 vs $0.63 (down 33.33%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Home reported interest income of $74.40MM vs $67.68MM (up 9.92%) and basic earnings per share $2.36 vs $2.34 (up 0.85%). Home is expected to report earnings on April 24th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.66. The estimated EPS forecast for the next fiscal year is $3.45 and is expected to report on January 29th, 2019.
To read the full Home Bancorp, Inc. (HBCP) report, download it here: http://Fundamental-Markets.com/register/?so=HBCP
-----------------------------------------
GORMAN-RUPP COMPANY (GRC) REPORT OVERVIEW
Gorman-Rupp's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Gorman-Rupp reported revenue of $94.94MM vs $94.20MM (up 0.78%) and basic earnings per share $0.31 vs $0.19 (up 63.16%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Gorman-Rupp reported revenue of $379.39MM vs $382.07MM (down 0.70%) and basic earnings per share $1.02 vs $0.95 (up 7.37%). Gorman-Rupp is expected to report earnings on April 26th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.23.
To read the full Gorman-Rupp Company (GRC) report, download it here: http://Fundamental-Markets.com/register/?so=GRC
-----------------------------------------
ARATANA THERAPEUTICS, INC. (PETX) REPORT OVERVIEW
Aratana Therapeutics' Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Aratana Therapeutics reported revenue of $10.46MM vs $0.29MM (up 3,481.16%) and basic earnings per share -$0.36 vs -$0.66. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Aratana Therapeutics reported revenue of $25.57MM vs $38.55MM (down 33.66%) and basic earnings per share -$1.17 vs -$0.95. Aratana Therapeutics is expected to report earnings on May 14th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.34. The estimated EPS forecast for the next fiscal year is -$0.16 and is expected to report on March 12th, 2019.
To read the full Aratana Therapeutics, Inc. (PETX) report, download it here: http://Fundamental-Markets.com/register/?so=PETX
-----------------------------------------
WASHINGTON REAL ESTATE INVESTMENT TRUST (WRE) REPORT OVERVIEW
Washington Real Estate Investment Trust's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Washington Real Estate Investment Trust reported revenue of $81.30MM vs $76.95MM (up 5.65%) and basic earnings per share $0.02 vs $0.11 (down 81.82%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Washington Real Estate Investment Trust reported revenue of $325.08MM vs $313.26MM (up 3.77%) and basic earnings per share $0.25 vs $1.65 (down 84.85%). Washington Real Estate Investment Trust is expected to report earnings on April 25th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.44. The estimated EPS forecast for the next fiscal year is $1.89 and is expected to report on February 21st, 2019.
To read the full Washington Real Estate Investment Trust (WRE) report, download it here: http://Fundamental-Markets.com/register/?so=WRE
-----------------------------------------
XG TECHNOLOGY, INC (XGTI) REPORT OVERVIEW
XG Technology's Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, XG Technology reported revenue of $10.16MM vs $1.91MM (up 431.00%) and basic earnings per share -$0.43 vs -$1.98. For the twelve months ended December 31st, 2016 vs December 31st, 2015, XG Technology reported revenue of $6.57MM vs $0.93MM (up 605.36%) and basic earnings per share -$36.87 vs -$332.32. XG Technology is expected to report earnings on March 30th, 2018. The report will be for the fiscal period ending December 31st, 2017.
To read the full XG Technology, Inc (XGTI) report, download it here: http://Fundamental-Markets.com/register/?so=XGTI
-----------------------------------------
HOPE BANCORP, INC. (HOPE) REPORT OVERVIEW
Hope's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Hope reported interest income of $153.19MM vs $135.39MM (up 13.15%) and basic earnings per share $0.13 vs $0.29 (down 55.17%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Hope reported interest income of $572.10MM vs $421.93MM (up 35.59%) and basic earnings per share $1.03 vs $1.10 (down 6.36%). Hope is expected to report earnings on April 26th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.28. The estimated EPS forecast for the next fiscal year is $1.67 and is expected to report on January 29th, 2019.
To read the full Hope Bancorp, Inc. (HOPE) report, download it here: http://Fundamental-Markets.com/register/?so=HOPE
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at [email protected].
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: [email protected]
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected].
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.


Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns
Meta AI Model Exploits Security Flaw During Cybersecurity Test, Raising AI Safety Concerns
DHL Q2 Profit Jumps 24% as Express Business Drives Growth
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves
Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan
UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions
Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations
Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales
Jetstar to Charge for Overhead Cabin Bags From February
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
BHP Port Hedland Strike Set to Proceed as Wage Talks Continue
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing 



